| Product NDC: | 65162-686 |
| Proprietary Name: | Felbamate |
| Non Proprietary Name: | Felbamate |
| Active Ingredient(s): | 600 mg/5mL & nbsp; Felbamate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65162-686 |
| Labeler Name: | Amneal Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202385 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111216 |
| Package NDC: | 65162-686-90 |
| Package Description: | 473 mL in 1 BOTTLE (65162-686-90) |
| NDC Code | 65162-686-90 |
| Proprietary Name | Felbamate |
| Package Description | 473 mL in 1 BOTTLE (65162-686-90) |
| Product NDC | 65162-686 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Felbamate |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20111216 |
| Marketing Category Name | ANDA |
| Labeler Name | Amneal Pharmaceuticals |
| Substance Name | FELBAMATE |
| Strength Number | 600 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |